Mark Bodenrader Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity

CERE Quotes by TradingView

Mark Bodenrader is of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Aug 01, 2024, when has been sold 17,724 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Mark Bodenrader Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2024
SELL
Sale (or disposition) back to the issuer
-
17,724 Reduced 100.0%
0 Common Stock
Dec 20 2023
SELL
Open market or private sale
$326,762 $41.42 p/Share
7,889 Reduced 30.8%
17,724 Common Stock
Dec 19 2023
BUY
Exercise of conversion of derivative security
-
19,284 Added 42.95%
25,613 Common Stock
Jun 02 2023
SELL
Open market or private sale
$62,440 $32.95 p/Share
1,895 Reduced 25.55%
5,522 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
-
4,733 Added 38.95%
7,417 Common Stock
MB

Mark Bodenrader

Cambridge, MA

Track Institutional and Insider Activities on CERE

Follow Cerevel Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if

Insider Trading

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if

News

Receive news related to Cerevel Therapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CERE